Member Info for Natdan

Looking at this rationally, why should the SP rise any further on expectation/anticipation alone?
The market is more likely to react positively on certainty. However much the optimists write as if this is the done deal Co., there is much crossing of t's and dotting of i's yet to be done.
The CE mark, as we all know and repeatedly pointed out helpfully by Twix at the time, missed its first quarter target for approval. As each day passes there is a tad more concern building that the worst case scenario of missing the second quarter could happen.
In the last update RNS I am sure that LR was trying to be as helpful as he could by hinting the CE certification will arrive. I do not recall however, ever coming across any RNS from any company stating that it's been "recommended for approval" and "final stages of evaluation." Its a done deal, almost.
As the SP has stagnated, I would expect the eventual CE announcement to be decently positive.
Other uncertainty would include the proposed new product launch (CE yet to be submitted) and no indications of the size of any revenues generated from the various Covid dabbling.
All in all, I do believe that once these unknowns have been banished to the bin, there is no reason why the SP should not motor and finally see it's much anticipated rerate.

QD- don't be surprised - this is what PF is good at- testing, trials and then nothing!
Please be aware of the mammoth shareholder value destruction over the last five years, of the order of 90%.
That is why the market reaction is so underwhelming - until something concrete is delivered for once, then it won't happen.

Usual tosh churned out today: yet another "trial" gimmick- the positive feedback reference is pure nonsense. Happy travellers? Wow.
No contract, no indication of any in the pipeline, and the Wsg usual mo trotted out of something vague in the future. Or not, as the case maybe.

Once the Twix ego has been massaged there is no stopping this poster. Nobody is surely remotely interested in the alleged buy/sell/ swing trades, none of which are verified in any way. This trader, if believed, has such volume as to regularly influence the SP in both directions.
For someone who has almost relentlessly talked down this Co. over the last five years, that is some claim. Not to mention the next forthcoming market crash - is this the prophet Jehovah in disguise?

Bakky, 6p was the lowest I got so not done too bad on average. But also have some at the 30p level!

CooperD,
Am glad to say am happily in positive territory here by averaging down over time, and will readily continue to hold.
Am also delighted with LR and the transformation he has achieved in relatively short order. However good the prospects and the company strategy, the SP performance is the one that matters. And it should by now be delivering. I am still Waiting for Godot.
Resuming radio silence now until good SP arrives.

Company of the year award nomination, JAdam, am all for it, but personally would much prefer SP performer of the year.
As a newbie but keen DYOR bod, am surprised you seem unaware this company has rightfully won such awards previously. Regrettably not reflected in the SP performance.
And the solution ? Oh yes, patience and sit it out a little longer. Am not negative, just realism takes hold after 5 years.

Can't help but think that had LR intended to provide any numbers he would have done so with last week's update. With results due in July then that is the logical time to give the current earnings figures, including forward looking.
It is clear the company is busy, so hopefully positive revenue streams to follow.
With regard to CE approval, the recent update strongly suggested it's a done deal, and yet over the week the SP barely moved. This being the case, I tend to believe this is more or less priced in: the great potential benefit in opening up the US market I doubt will be an overnight transformation.
Sorry to say, with the constant SP selling still apparently unresolved I think June will be time to sit it out as the SP remains range-bound.

At first I thought it was just me but the consensus now appears to be that Ncyt from our Company perspective could be a 'wrong-un'. It did seem strange in the 26/5 update that not a single mention was made of the new bride - I fear a divorce before even a proper consummation and delayed honeymoon has taken place.
That said, the info. provided to us to date is that on 25/3 the Co.signed " a contract manufacturing agreement" with Ncyt. The 20/4 trading briefly confirmed that the"first shipments are now completed," so presumably revenue attached.
I would expect that the two are still working together as any termination of said contract -mutually or otherwise- would likely necessitate a RNS.
My guess is LR is not a happy teddy presently as delay has been caused by need to introduce the go-it-alone test.
Short term drift perhaps, re-energised as CE arrives and the test is launched.

bottom_feeder. I cross myself each morning just before 7am, hoping for positive divine intervention.

Interesting theory Bottom, but I do believe a China purchase of tests generated the government seeking a refund on quality grounds.
I would have thought that if Ncyt was subject of that refund request, it should have generated a RNS from them as a material announcement.
I suggested yesterday that the Ygen announcements to date, though positive, have failed to provide sufficient concrete information on the extent of their Covid involvement.
Until numbers are provided there remains an element of speculation.
Back to the core business for now, the Ncyt link has become a distraction.

Baking/ CooperD - agree with the overall sentiment. However, for whatever reason it seems Mr Market wants to see at least some money before pushing ahead.
This has not been lumped into the Covid euphoria stocks, and there must be an explanation, especially since we are already churning out product.
In the meantime, the CE mark would likely release the handbrake

It is most disappointing, at least short-term, to see the market refuses to push this over the 20p psychological barrier.
Why is this?
Three recent broadly positive RNSs have hardly dented the market's sentiment towards this company: we are still a country mile away from the all time high in the low 30s reached around five years ago.
The market sometimes has a long memory and I wonder if it is being over cautious because of this company's past car-crash scenario.
LR has certainly transformed the company, of that there is no doubt.
Trading in the core business is described as being in line, which is a positive. The CE marker is now urgently needed in order to propel the next leg up in markets and earnings.
The great unknown at the moment is the Covid-effect. There is a sense perhaps that Ygen was late off the starting blocks, but is possibly coming up on the inside with a superior, more accurate and better quality product.
Time will tell. I note even LR sounded a note of caution in stating "demand and uptake is difficult to forecast."
So at the risk of upsetting some of the newbies here, I would suggest the market has decided to wait and see the money before they decide to follow it. "Blame it on the MMs " doesn't really wash.

JAdam, I asked the question re Testing in good faith, because to me it was unclear in a number of regards, esp. the Ncyt tie-up. Still is, but am more than happy with developments to date and the skin I have in the game.
In truth it comes as no surprise when the odd key-board warrior such as yourself tries to impress the community with the breadth and extent of your infallibility and pseudo-superiority.
Nothing further to add to your vitriol as it risks tarnishing this generally helpful and good-humoured board.
30p soon, anybody?

JAdam, no belittling of the company intended, and it seems you too may be confused as to YGEN's current position re testing situation. You certainly provided no answers, otherwise why bat the question off with a non-committal dyor? The benefit of your own research? Do me a favour.
I asked the question genuinely, your response is uncivil.
I am more than happy as a long-term holder, more for the core business and forthcoming CE implications.
Thanks for your, er...insight.

jAdam- thanks for reply, a touch condescending as it may be.
I have been here since NIPT, day one, and have no intention of selling up.
the recent three updates show a fast-moving company behind the scenes, but I personally found the updates taken in the round to be confusing.
With NCYT, for example we were told we are providing components (widget maker) with possibility of becoming self-sufficint. Where are we at presently?
Perhaps JAdam you could provide the benefit of your knowledge by summarising in a couple of sentences how you see the current testing position of Ygen.

Have read and re-read the three most recent updates provided by the Company in relation specifically to its Covid strategy, and admit to being more than a tad confused.
Would be grateful for any clarification, perhaps during the wed. trading day.
The 25 March rns announced a contractual manufacturing agreement with Ncyt. I was surprised there was no specific mention of this arrangement in today's update and, indeed, whether it is still in force and progressing. I assume so unless told otherwise.
LIkewise the march communication made reference to lab-service testing for the NHS. Nothing since, so no ideas if this potential revenue source has legs or not.
The 20 April trading update confirmed that first shipments of the (Ncyt agreement?) had been completed, so presumably revenue generating.
Today's update seems to add further momentum to the Covid front with the launch of its testing service and the proposed Clarigene infectious disease kit.
I have the strong sense that the Co. strategy appears to be aiming for potentially more lucrative fields within the Covid arena, and that LR has already seen beyond Ygen as a mere widget assembler and sub-contractor for the mass-produced Ncyt product.
To be perfectly honest, all this testing in a fast-moving market is doing my head in. That said, I have every faith LR has a cunning plan.
An idiot's guide to Covid testing Vis-a-Vis Ygen would be gratefully appreciated.

Generally very positive update. Especially good to hear the awaited CE is as good as in the bag, and the core business trading in line.
Seems LR has decided to chase the Covid market independently. No mention of Ncyt, perhaps they are being given the cold-shoulder .
Pleasing all round.

Apologies pacman, should have checked with dummy trade first!
Feeling rosier now. Still need news tho.

Seems to be no end to the selling.
Crying out for news. any news.